05 Mar |
![]() India’s Clinical Trials Market: Can We Leap from Underdog to Global Leader?The stakes are high, the challenges are many, and the rewards could be transformative not just for India, but for global healthcare as well. View |
14 Sep |
![]() Seeking Justice: The Tragic Case of Jaahnavi Kandula and the inhumanity of US policeJaahnavi's life ended tragically in a police car collision during her Master's pursuit. A detective's callous 'jokes' about her death emphasize the need for empathy and accountability in law enforcement. View |
31 Jul |
![]() Revolutionizing Medicine: AI and Brain Implants Restore Sensation to Paralyzed ManThe groundbreaking application of AI and brain implants offers hope to many paralyzed individuals, paving the way for potential advancements in medical science and improving the quality of life for those living with severe physical disabilities. View |
11 Aug |
![]() Now that Eyestem is here, Can India now be care free about Dry AMD ?Dry AMD is the largest cause of incurable blindness in people above 60 and affects roughly 170 million people worldwide.The investment will allow Eyestem to progress treatment for Dry Age-related Macular Degeneration into clinical trials. View |
08 Aug |
![]() Eyestem raises $6.4M in Series A roundThe investment will allow Eyestem to progress a treatment for Dry Age-related Macular Degeneration into clinical trials. View |
22 Jun |
![]() Signs and Symptoms of Alzheimer’s DiseaseAlzheimer's disease is a disease that makes no distinctions and takes no sides. It is equally drawn to the wealthy and the impoverished, the famous and the ordinary. View |
23 Aug |
![]() Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106Latest Pharma Update View |
16 Jul |
![]() Idifarma launches accelerated pathway for complex drugsThe new service also aims to maximize yield and minimize waste of API View |
20 Mar |
![]() Fujitsu Embarks on Joint Research with National Cancer Center JapanThe joint research is aimed to create new services for drug development and clinical trials View |
24 Dec |
![]() Serum Institute Of India And Dynavax Announce First Participants Dosed In The Phase 1/2 Clinical Trial For A COVID-19 VaccineSerum Institute Of India And Dynavax, today jointly announced that the first participants have been dosed in the Phase 1 part of the Phase 1/2 clinical trial evaluating SIIPL's vaccine candidate adjuvanted with CpG 1018 to prevent COVID-19. View |
![]() |
![]() |
![]() |
![]() |